Novo Nordisk's (NVO) acquisition of three Catalent (CTLT) production sites to close soon as its parent wins regulatory nod ...

Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their ...

Catalent Inc. (CTLT)股价已达到显著的52周高点，触及62.51美元，因为该公司继续在制药和生物技术解决方案板块乘势上涨。市值113亿美元的Catalent，根据 InvestingPro ...

Robert W. Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock ...

Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $63.24 which represents a slight increase of $1.00 or 1.61% from the prior close of $62.24. The stock opened at $62.5 and touched a low ...

Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission ...

Novo Nordisk (NVO) announced that as of today, all regulatory closing conditions relating to the review of its pending acquisition of Catalent ...

Catalent Inc. (CTLT)股价已达到显著的52周新高，触及61.68美元，市值达111.5亿美元。根据 InvestingPro 分析，该股票似乎正在其公允价值之上交易，而分析师目标价表明可能上涨至63.50美元。这一里程碑反映了自去年以来的显著上升趋势，过去12个月股票回报率达53%，今年至今更是实现了36.72%的impressive涨幅。股价升至52周新高凸显了市场对Catal ...

智通财经APP获悉，据报道，欧盟委员会可能将无条件批准诺和诺德(NVO.US)母公司Novo Holdings以165亿美元收购美国合同制药商Catalent(CTLT.US)的交易。

A month has gone by since the last earnings report for Catalent (CTLT). Shares have added about 3.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

It will now receive $3.10 a share in a revised takeover agreement, down from the original price of $6.66. Catalent (CTLT) ...

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition Roche reported a 9% increase in third-quarter sales, driven by strong ...